We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $2.84M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 22 → 22 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
6% less capital invested
Capital invested by funds: $3.01M → $2.84M (-$166K)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
5
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$32.6K |
| 3 |
BlackRock
New York
|
+$29.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.55K |
